Literature DB >> 19463781

The circular bacteriocin, carnocyclin A, forms anion-selective channels in lipid bilayers.

Xiandi Gong1, Leah A Martin-Visscher, Drew Nahirney, John C Vederas, Marek Duszyk.   

Abstract

Bacterial resistance to conventional antibiotics is a major challenge in controlling infectious diseases and has necessitated the development of novel approaches in antimicrobial therapy. One such approach is the use of antimicrobial peptides, such as the bacterially produced bacteriocins. Carnocyclin A (CclA) is a 60-amino acid circular bacteriocin produced by Carnobacterium maltaromaticum UAL307 that exhibits potent activity against many Gram-positive bacteria. Lipid bilayer and single channel recording techniques were applied to study the molecular mechanisms by which CclA interacts with the lipid membrane and exerts its antimicrobial effects. Here we show that CclA can form ion channels with a conductance of 35 pS in 150 mM NaCl solution. This channel displays a linear current-voltage relationship, is anion-selective, and its activation is strongly voltage-dependent. The formation of ion channels by CclA is driven by the presence of a negative membrane potential and may result in dissipation of membrane potential. Carnocyclin A's unique functional activities as well as its circular structure make it a potential candidate for developing novel antimicrobial drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463781     DOI: 10.1016/j.bbamem.2009.05.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Complete genome sequence of Carnobacterium sp. 17-4.

Authors:  Sonja Voget; Barbara Klippel; Rolf Daniel; Garabed Antranikian
Journal:  J Bacteriol       Date:  2011-05-06       Impact factor: 3.490

2.  Solution structure of acidocin B, a circular bacteriocin produced by Lactobacillus acidophilus M46.

Authors:  Jeella Z Acedo; Marco J van Belkum; Christopher T Lohans; Ryan T McKay; Mark Miskolzie; John C Vederas
Journal:  Appl Environ Microbiol       Date:  2015-02-13       Impact factor: 4.792

Review 3.  Circular bacteriocins: biosynthesis and mode of action.

Authors:  Christina Gabrielsen; Dag A Brede; Ingolf F Nes; Dzung B Diep
Journal:  Appl Environ Microbiol       Date:  2014-08-29       Impact factor: 4.792

4.  Characterization of garvicin ML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from mallard ducks (Anas platyrhynchos).

Authors:  Juan Borrero; Dag A Brede; Morten Skaugen; Dzung B Diep; Carmen Herranz; Ingolf F Nes; Luis M Cintas; Pablo E Hernández
Journal:  Appl Environ Microbiol       Date:  2010-11-05       Impact factor: 4.792

5.  The ABC Transporter CclEFGH Facilitates the Production of the Circular Bacteriocin Carnocyclin A.

Authors:  Marco J van Belkum; John C Vederas
Journal:  Probiotics Antimicrob Proteins       Date:  2012-12       Impact factor: 4.609

6.  Cloning and Characterization of the Gene Cluster Involved in the Production of the Circular Bacteriocin Carnocyclin A.

Authors:  Marco J van Belkum; Leah A Martin-Visscher; John C Vederas
Journal:  Probiotics Antimicrob Proteins       Date:  2010-12       Impact factor: 4.609

7.  Plantaricyclin A, a Novel Circular Bacteriocin Produced by Lactobacillus plantarum NI326: Purification, Characterization, and Heterologous Production.

Authors:  Juan Borrero; Eoin Kelly; Paula M O'Connor; Philip Kelleher; Colm Scully; Paul D Cotter; Jennifer Mahony; Douwe van Sinderen
Journal:  Appl Environ Microbiol       Date:  2017-12-15       Impact factor: 4.792

8.  The maltose ABC transporter in Lactococcus lactis facilitates high-level sensitivity to the circular bacteriocin garvicin ML.

Authors:  Christina Gabrielsen; Dag A Brede; Pablo E Hernández; Ingolf F Nes; Dzung B Diep
Journal:  Antimicrob Agents Chemother       Date:  2012-03-12       Impact factor: 5.191

9.  Stress response and adaptation of Listeria monocytogenes 08-5923 exposed to a sublethal dose of carnocyclin A.

Authors:  Xiaoji Liu; Urmila Basu; Petr Miller; Lynn M McMullen
Journal:  Appl Environ Microbiol       Date:  2014-04-18       Impact factor: 4.792

Review 10.  Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.

Authors:  Paul G Arnison; Mervyn J Bibb; Gabriele Bierbaum; Albert A Bowers; Tim S Bugni; Grzegorz Bulaj; Julio A Camarero; Dominic J Campopiano; Gregory L Challis; Jon Clardy; Paul D Cotter; David J Craik; Michael Dawson; Elke Dittmann; Stefano Donadio; Pieter C Dorrestein; Karl-Dieter Entian; Michael A Fischbach; John S Garavelli; Ulf Göransson; Christian W Gruber; Daniel H Haft; Thomas K Hemscheidt; Christian Hertweck; Colin Hill; Alexander R Horswill; Marcel Jaspars; Wendy L Kelly; Judith P Klinman; Oscar P Kuipers; A James Link; Wen Liu; Mohamed A Marahiel; Douglas A Mitchell; Gert N Moll; Bradley S Moore; Rolf Müller; Satish K Nair; Ingolf F Nes; Gillian E Norris; Baldomero M Olivera; Hiroyasu Onaka; Mark L Patchett; Joern Piel; Martin J T Reaney; Sylvie Rebuffat; R Paul Ross; Hans-Georg Sahl; Eric W Schmidt; Michael E Selsted; Konstantin Severinov; Ben Shen; Kaarina Sivonen; Leif Smith; Torsten Stein; Roderich D Süssmuth; John R Tagg; Gong-Li Tang; Andrew W Truman; John C Vederas; Christopher T Walsh; Jonathan D Walton; Silke C Wenzel; Joanne M Willey; Wilfred A van der Donk
Journal:  Nat Prod Rep       Date:  2013-01       Impact factor: 13.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.